AlphAIAlphAI — Financial news for AI agents
healthcare-digital.comOCT 83 min read$MCK

McKesson & CD&R Acquire Leading US Home-Infusion Platform

McKesson and private equity firm CD&R will acquire Option Care Health, a US home-infusion care provider, for $5.8bn. CD&R will take a majority stake, while McKesson invests $1.4bn for a minority stake. The deal values Option Care Health at $32.05 per share and is expected to close in H1 2027. McKesson aims to leverage the acquisition to expand its specialty care offerings.

Original reporting
healthcare-digital.com
Published Oct 8, 2026, 11:00 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 8, 2026, 11:55 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
McKesson & CD&R Acquire Leading US Home-Infusion Platform — source image
Source · healthcare-digital.com
Decision brief

The 30-second read

$MCKBullishHigh
01

Why it matters

The transaction provides McKesson with a foothold in outpatient infusion, expanding its specialty pharma logistics network.

02

Market read

Large M&A deal in healthcare distribution sector with immediate price impact potential for both acquirer and target.

03

What to watch

Regulatory approvals and integration risks could delay expected synergies.

Relevance 9/10Novelty 9/10Timing: today

Background

McKesson partners with private‑equity firm CD&R to acquire Option Care Health, a leading U.S. home‑infusion platform.

Company-level read

Ticker impact

$MCKBullishHigh confidence
Context

McKesson announced a $5.8bn acquisition of Option Care Health, taking a minority stake worth $1.4bn.

Expected impact

likely upward pressure as investors price in strategic expansion and cash deployment.

Evidence & confidence

Large‑scale M&A with clear strategic rationale; market typically rewards such announcements.

Market effects

Sector

Strengthens the home‑infusion and specialty pharma distribution sector, signaling consolidation and potential margin expansion.

Regional

U.S. healthcare distribution market may see increased M&A activity as firms seek scale.

Global

Highlights growing importance of outpatient infusion services worldwide.

Counterpoint

What could challenge this read

Deal could strain McKesson's balance sheet and distract from core distribution business.

Key entities

  • Company
    McKesson

    U.S. healthcare distributor and acquirer.

  • Company
    Option Care Health

    Provider of outpatient infusion services.

  • Private Equity
    Clayton, Dubilier & Rice

    Majority stakeholder in the transaction.

Read at source← All news

StoryMcKesson and CD&R agree $5.8 bn acquisition of Option Care Health

Also covered by

5 outlets

Related articles

OCT 7
$OPCHHighAI 9/10

Option Care stock surges on McKesson's home-infusion bet

Option Care Health (OPCH) shares rose 33% to $31.11 after McKesson (MCK) and Clayton, Dubilier & Rice agreed to take it private for $32.05 per share, valuing it at $5.8B. McKesson will initially own 49%, with an option to acquire the rest later. The deal gives McKesson access to Option Care's home-infusion network, serving 315K+ patients. Option Care's Q2 revenue grew 1.9% to $1.44B. The deal needs shareholder and regulatory approvals to close in early 2027.

finance.yahoo.com2 min
OCT 7
$MCKHighAI 9/10

McKesson Plans $1.4 Billion Stake in $5.8 Billion Option Care Buyout

McKesson plans a $1.4B investment for a 49% stake in Option Care Health, part of a $5.8B buyout by Clayton, Dubilier & Rice. Shareholders will receive $32.05 per share. The deal, pending approvals, is expected to close in early 2027. Option Care shares rose 32.7% on the news. McKesson's Q1 revenue grew 8% to $105.4B, with net income down 22% to $614M.

finchannel.com2 min
OCT 7
$MCKHighAI 9/10

McKesson, private equity firm buy home infusion company, Option Care Health

McKesson Corporation and private equity firm Clayton Dubilier & Rice (CD&R) agreed to acquire Option Care Health, a home infusion company, for $5.8 billion. McKesson will invest $1.4 billion for a 49% stake, with CD&R taking 51%. The deal values Option Care Health at $32.05 per share, a 36% premium over Monday's closing price. Once completed, Option Care Health will become private and delist from Nasdaq.

managedhealthcareexecutive.com2 min
OCT 7
$MCKHighAI 9/10

McKesson, CD&R to Buy Option Care for $5.8B

McKesson Corp. and private equity firm Clayton, Dubilier & Rice will acquire Option Care Health Inc. for $5.8 billion, or $32.05 per share, a 37% premium. McKesson will own 49%, with CD&R as the controlling shareholder. Option Care, a major provider of home and outpatient infusion care, will retain its management team. The deal aligns with McKesson's strategy to expand specialty care services, potentially increasing its ownership over time.

briefs.co2 min